Copyright
©The Author(s) 2019.
World J Gastroenterol. Jan 28, 2019; 25(4): 457-468
Published online Jan 28, 2019. doi: 10.3748/wjg.v25.i4.457
Published online Jan 28, 2019. doi: 10.3748/wjg.v25.i4.457
Table 6 Comparison of characteristics among patients receiving dual antiplatelet therapy in the continuous low-dose aspirin group and the discontinuous low-dose aspirin group
| Continuous LDA (n = 39) | Discontinuous LDA (n = 20) | P value | |
| Age, mean (SD), yr | 74.7 (7.743) | 77.4 (7.665) | 0.216 |
| Sex, male, n (%) | 34 (87.2) | 14 (70.0) | 0.159 |
| BMI, mean (SD), yr | 23.5 (3.765) | 22.4 (3.232) | 0.273 |
| Comorbidity, n (%) | |||
| Hypertension | 29 (74.4) | 15 (75.0) | > 0.99 |
| Diabetes mellitus | 19 (48.7) | 8 (40.0) | 0.589 |
| Renal failure | 4 (10.3) | 3 (15.0) | 0.679 |
| Coronary artery diseases | 37 (94.9) | 17 (85.0) | 0.325 |
| Longitudinal location, n (%) | |||
| Upper | 10 (25.6) | 3 (15.0) | 0.726 |
| Middle | 12 (30.8) | 7 (35.0) | |
| Lower | 17 (43.6) | 10 (50.0) | |
| Macroscopic findings, n (%) | |||
| Depressed | 11 (28.2) | 5 (25.0) | > 0.99 |
| Non-depressed | 28 (71.8) | 15 (75.0) |
- Citation: Harada H, Suehiro S, Murakami D, Nakahara R, Nagasaka T, Ujihara T, Sagami R, Katsuyama Y, Hayasaka K, Amano Y. Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy. World J Gastroenterol 2019; 25(4): 457-468
- URL: https://www.wjgnet.com/1007-9327/full/v25/i4/457.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i4.457